Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Gemcitabine, dexamethasone, cisplatin (GDP)...
Conference

Gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy for relapsed or refractory Hodgkin's disease (HD): A National Cancer Institute of Canada Clinical Trials Group Study.

Authors

Crump M; Baetz T; Belch A; Couban S; Meyer R; Imrie K; Yau J; Myers R; Paul N; Turner R

Volume

100

Pagination

pp. 570A-570A

Publisher

AMER SOC HEMATOLOGY

Publication Date

November 16, 2002

Name of conference

44th Annual Meeting of the American-Society-of-Hematology

Conference place

PHILADELPHIA, PENNSYLVANIA

Conference start date

December 6, 2002

Conference end date

December 10, 2002

Conference proceedings

BLOOD

Issue

11

ISSN

0006-4971